Détail du blog
Cold Chain Technologies repense le système d'expédition biopharmaceutique pour réduire la dépendance à la glace carbonique
Cold Chain Technologies a achevé la refonte du système d'expédition à température contrôlée d'un client biopharmaceutique mondial, remplacement d'une ancienne solution de glace carbonique et d'EPS par une stratégie d'emballage basée sur les données.
Le projet a commencé par une analyse des modèles d'expédition réels. Plus de la moitié des commandes des clients contenaient trois cartons ou moins, indicating that its existing packaging was often larger than necessary. By creating a more targeted range of shipment sizes, the new design reduces empty space, material use and freight inefficiency.
The replacement system combines paper-based thermal packaging with a water-based refrigerant carton. The aim is to maintain the required thermal protection while reducing dependence on dry ice, which can add safety, handling and regulatory complexity across warehousing and fulfilment operations.
Lifecycle assessment work showed that the paper-based option delivered the lowest environmental impact among the evaluated insulation choices, while the water-based refrigerant performed more favourably than dry ice from a sustainability perspective. The redesigned packaging also gives recipients a simpler disposal process, helping improve the end-user experience.
The project reflects a broader shift in pharmaceutical cold-chain logistics: packaging is increasingly being designed around real shipment profiles, thermal performance and end-of-life management—not only around temperature duration.
